Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30526506 | 1.00 | HDAC1 (1.00) | HDAC1 | |
| SCHEMBL29049338 | 1.00 | HDAC1 (1.00) | HDAC1 | |
| SCHEMBL29049418 | 0.99 | HDAC1 (1.00) | HDAC1 | |
| SCHEMBL29049421 | 0.99 | HDAC1 (1.00) | HDAC1 | |
| SCHEMBL29049284 | 0.95 | HDAC1 (1.00) | HDAC1 | |
| SCHEMBL29049279 | 0.95 | HDAC1 (1.00) | HDAC1 | |
| SCHEMBL31412064 | 0.89 | HDAC1 (0.80) | HDAC1 | |
| SCHEMBL29049377 | 0.89 | HDAC1 (0.80) | HDAC1 | |
| SCHEMBL29049402 | 0.89 | HDAC1 (0.80) | HDAC1 | |
| SCHEMBL29049344 | 0.88 | HDAC1 (1.00) | HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124191-A1 | HISTONE DEACETYLASE INHIBITOR AND USES THEREOF | NANJING HONGSHUN PHARMACEUTICAL TECHNOLOGY CO., LTD (CN) | 2026-05-07 | — | — | US | disclosed |
| EP-4725940-A1 | HISTONE DEACETYLASE INHIBITOR AND USE | Nanjing Hongshun Pharmaceutical Technology Co., Ltd (CN) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025011398-A1 | HISTONE DEACETYLASE INHIBITOR AND USE | 南京市鸿舜医药科技有限公司 | 2025-01-16 | — | — | WO | disclosed |
| CN-116554079-B | Histone deacetylase inhibitor and application thereof | 南京市鸿舜医药科技有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116554079-A | Histone deacetylase inhibitor and application thereof | 南京市鸿舜医药科技有限公司 | 2023-08-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260124191-A1 | HISTONE DEACETYLASE INHIBITOR AND USES THEREOF | HDAC1, HDAC3, HDAC2 | HDAC1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.